Kyowa Hakko Kogyo Co., Ltd. To Introduce Self-Injectable Drug For Treating Parkinson’s Disease From Britannia Pharmaceuticals Limited

February 23, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Tokyo, Feb 23, 2006 (JCN) - Kyowa Hakko Kogyo announced on February 22 that it has concluded a licensing agreement with UK company Britannia Pharmaceuticals for a self-injectable formulation of apomorphine.

Twitter
LinkedIn
Facebook
Email
Print

Alliances Asia